theMednetRegister
  • Community
    • Overview
    • Experts
    • Editors
    • Fellows
    • Code of conduct
    • AI Guidelines for Physicians
  • Company
    • About Us
    • FAQs
    • Privacy Policy
    • Terms of Use
    • Careers
    • Programs
  • News
    • News Releases
    • Press Coverage
    • Publications
    • Blog
  • Contact Us
  • Sign in

Dermatology

Primary Immunodeficiency   

Questions discussed in this category


How would you approach diagnosis of a patient with recurrent episodes of abdominal pain, severe myalgias, low grade fevers and urticaria?
Does this presentation fall within the autoinflammatory spectrum, and is it consistent with FMF or would you consider another cytokine-driven process?...
4 Answers available

What approaches can we take to initiate therapy and improve survival rates in patients with HLH?
2 Answers available

When would you pursue genetic testing for severe recalcitrant atopic dermatitis?
1 Answer available

Would you avoid combining JAK inhibitors with IVIG given the risk of thromboembolism?
4 Answers available

How do you handle hypogammaglobulinemia detected in patients prior to maintenance rituximab infusion?
2 Answers available
241911927720979168028485


Papers discussed in this category


JAMA network open, 2018-11-02
Association of Immunoglobulin Levels, Infectious Risk, and Mortality With Rituximab and Hypogammaglobulinemia.

N Engl J Med, 2022 Oct 06
Trial of Intravenous Immune Globulin in Dermatomyositis.

Arthritis & rheumatology (Hoboken, N.J.), 2023 Jul 24
The 2022 EULAR/ACR Points to Consider at the Early Stages of Diagnosis and Management of Suspected Haemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome (HLH/MAS).

Related Topics in Dermatology

  • Lung Cancer
  • Breast Cancer
  • Head and Neck Cancers
  • Hematologic Malignancies
  • Radiation Oncology
  • Gynecologic Oncology
  • Palliation
  • Gastrointestinal Cancers
  • Genitourinary Cancers
  • Melanoma/Skin Cancer

Copyright © 2025 theMednet
All Rights Reserved.